LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
2.647
-0.113 (-4.09%)
At close: May 17, 2024, 3:59 PM
2.740
+0.093 (3.51%)
After-hours: May 17, 2024, 5:17 PM EDT
LAVA Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for LAVA Therapeutics stock have an average target of 6.00, which predicts an increase of 126.67% from the current stock price of 2.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2024.
Analyst Ratings
The average analyst rating for LVTX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +126.67% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +126.67% | Nov 17, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +126.67% | Aug 23, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +126.67% | Aug 23, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +126.67% | Jun 15, 2023 |
Financial Forecast
Revenue This Year
7.14M
from 6.77M
Increased by 5.48%
Revenue Next Year
n/a
from 7.14M
EPS This Year
-1.54
from -1.57
EPS Next Year
-2.10
from -1.54
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.4M | n/a | n/a | 5.4M | 59.3M |
| Avg | 7.1M | n/a | n/a | 2.3M | 39.7M |
| Low | 6.9M | n/a | n/a | n/a | 25.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.6% | - | - | - | 2,450.5% |
| Avg | 5.5% | - | - | - | 1,608.6% |
| Low | 1.3% | - | - | - | 993.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.37 | -1.61 | -1.63 | -1.36 | -0.68 |
| Avg | -1.54 | -2.10 | -1.74 | -1.62 | -1.20 |
| Low | -1.71 | -2.86 | -1.82 | -1.85 | -1.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.